title: Comorbidity assessment and radiotherapy in elderly cancer patients.
abstract: More than 60% of all cancer patients in Europe and the USA are older than 65 years at the time of diagnosis. Despite this, elderly patients are generally under-represented in clinical trials. There is a lack of clinical trials to drive evidence-based decision making in the elderly cancer patients.  In this review, we address the most important issue surrounding the treatment of older cancer patients: comorbidity assessment.
authors.affiliation: Department of Radiation Oncology, University Hospital, Ferrara, Italy. francesco.fiorica@unife.it
authors.forename: F
authors.initials: F
authors.lastname: Fiorica
authors.forename: A
authors.initials: A
authors.lastname: Stefanelli
authors.forename: R
authors.initials: R
authors.lastname: Fisichella
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
authors.forename: M
authors.initials: M
authors.lastname: Berretta
mesh_terms: D000368:Aged; D015897:Comorbidity; D006801:Humans; D017567:Karnofsky Performance Status; D009369:Neoplasms / Q000453:epidemiology* / Q000532:radiotherapy*